Deputy Director of the Department of Tumor Interventional Radiology at Renji Hospital, Associate Chief Physician, Master's Supervisor MD from Sun Yat-sen University, Postdoctoral Fellow at Washington University School of Medicine (Seattle), USA Clinical Expertise: ① Comprehensive interventional treatment (ablation, transarterial infusion chemotherapy/embolization, radioactive particle implantation, etc.) for various malignant solid tumors including liver cancer, lung cancer, and renal cancer; ② Diagnosis and minimally invasive ablation treatment of pulmonary nodules and thyroid nodules; ③ Interventional embolization treatment for large hepatic hemangioma, splenomegaly/hypersplenism, uterine fibroids/adenomyosis, renal angiomyolipoma, benign prostatic hyperplasia, and other diseases; ④ Percutaneous transhepatic cholangial drainage (PTCD), sclerotherapy for hepatic and renal cysts; ⑤ Interventional embolization treatment for various types of hemorrhage (including hemoptysis, gastrointestinal bleeding, renal bleeding, etc.); ⑥ Ultrasound- and CT-guided percutaneous biopsy of various diseases. 【Research Achievements】 As first author (including co-first author), published 15 original research articles in SCI journals including Nature, STTT, Radiology, Clinical Cancer Research, and Cancer Communication, and 5 original research articles in Chinese core journals; Principal Investigator of 1 National Natural Science Foundation of China project, 1 Shanghai Natural Science Foundation project, and 1 Society of Interventional Radiology (SIR) Foundation project; Principal Investigator of 2 Renji Hospital Clinical Research Innovation Cultivation Fund projects; as a major participant, involved in multiple projects funded by the Ministry of Science and Technology of China, the National Natural Science Foundation of China, and the Shanghai Municipal Science and Technology Commission; contributed to the compilation of 3 monographs. 【Research Directions】 Comprehensive interventional therapy and targeted immunotherapy for malignant tumors, with particular emphasis on basic research and clinical translational research in comprehensive treatment of liver cancer. 【Personal Honors】 Received the Trainee Research Prize at the 2014 North American RSNA Annual Meeting; as a principal investigator, participated in a research project selected for the Third "Top Ten Scientific and Technological Advances" of Shanghai Jiao Tong University; awarded the 2024 Interventional Rising Star at the Chinese College of Interventionalists (CCI) Annual Meeting of the Chinese Medical Doctor Association.